Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_2
2
50%
Ph not_applicable
1
25%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (50.0%)
Phase 31 (25.0%)
N/A1 (25.0%)

Trials by Status

completed250%
terminated125%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_3

RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty

NCT03064126
completednot_applicable

IN.PACT™ AV Access IDE Study

NCT03041467
terminatedphase_2

European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)

NCT01260870
unknownphase_2

Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial)

NCT01247402

Clinical Trials (4)

Showing 4 of 4 trials
NCT03064126Phase 3

RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty

Completed
NCT03041467Not Applicable

IN.PACT™ AV Access IDE Study

Completed
NCT01260870Phase 2

European Study of POBA Versus Cotavance(R) Paclitaxel Coated Balloon for the Treatment of Infrapopliteal Lesions in Critical Limb Ischemia (EURO CANAL)

Terminated
NCT01247402Phase 2

Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial)

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4